A Study of Channel Member Satisfaction and Ensuing Commitment in International and Domestic Pharmaceutical Distribution Channels

2014 ◽  
Vol 44 (1) ◽  
pp. 44
Author(s):  
Reeva Paul
1980 ◽  
Vol 44 (3) ◽  
pp. 52-64 ◽  
Author(s):  
Louis W. Stern ◽  
Torger Reve

This paper presents a unifying framework for the analysis of distribution channels which encompasses both economic and sociopolitical determinants of channel member behavior and provides a suitable departure point for comparative work. The framework integrates present approaches to the study of marketing channels and provides an essential, but heretofore missing, basis for comprehensive empirical research in the area.


2021 ◽  
pp. 027614672110257
Author(s):  
James R. Brown

The author reviews his relationship with Professor Robert F. Lusch, including joint research with some of their doctoral students. Their work addressed questions pertaining to marketing channel power and dependence, channel conflict, and channel member satisfaction as well as contracting among channel member firms.


Author(s):  
George Malindretos

The scope of this chapter is to provide useful insights of the pharmaceutical supply chain and identify the prospects of outsourcing, with special reference to the Greek pharmaceutical sector. This goal is facilitated by a threefold analysis in combination: first, by the development of an integrated interdisciplinary research methodology framework; second, by the identification of the special characteristics of the pharmaceutical supply chain with special attention to the role of outsourcing; and third, by the description of the current pharmaceutical distribution channels in Greece and the identification of the potential opportunities for outsourcing. The findings of this study are outlined in an attempt to contribute in the yet unsettled research methodology issue which has particular importance for the R&D in the pharmaceutical sector. Certain specific suggestions for future research are expected to support the sustainability of the Greek pharmaceutical sector, with potential broader relevance.


1985 ◽  
Vol 13 (1-2) ◽  
pp. 188-205 ◽  
Author(s):  
Donald A. Michie ◽  
Stanley D. Sibley

1984 ◽  
Vol 21 (2) ◽  
pp. 226-233 ◽  
Author(s):  
Robert W. Ruekert ◽  
Gilbert A. Churchill

The authors describe the development of multiple-item measures to capture the construct of channel member satisfaction. Two measures are developed that are found to have high levels of reliability and validity. In addition, the construct of channel member satisfaction is found to be multidimensional, involving satisfaction with products, financial considerations, social interaction, cooperative advertising programs, and other promotional assistances.


2020 ◽  
Vol 12 (11) ◽  
pp. 4787
Author(s):  
Jelena Grujić ◽  
Slobodan Morača ◽  
Angela Fajsi

The subject of this paper is pharmaceutical companies and the risk factors that occur in the distribution of drugs. The paper will present guidelines for the risk management of changes in the environment of pharmaceutical distribution channels. To identify, analyse, and prioritise risks, we used a systematic literature review and the Delphi method. Identification and assessment of important risk factors in drug distribution channels were conducted based on opinions of experts from 10 international pharmaceutical companies operating in Southeast Europe. The purpose of the research was to get opinions from experts about the impacts of the risk factors on the distribution of drugs, which was accomplished through interviews and questionnaires that were conducted. Our study demonstrated a total of 78 risk factors in the distribution channels of drugs and pharmaceutical services. The results of the research combined separate evaluations for risk factors in all categories for easier data analysis. After data were obtained, results were arranged to show which risk factors had the biggest influence upon the distribution of drugs and to determine the negative effects they can produce. The research of risks was done primarily to help the representatives of distribution channels gain better insight into drug distribution.


Sign in / Sign up

Export Citation Format

Share Document